CompletedNCT00997984
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
ADHDOtherFrom 6 Years to 12 Years
- Countries
- Canada, United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT03327402
This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
ADHDOtherFrom 4 Years to 5 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT00506727
This study exists to compare options and see whether this type of care offers something meaningfully different. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.
ADHDOtherFrom 6 Years to 12 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT00507065
This study exists to learn from real-world information that can show how this type of care fits into care. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
ADHDOtherFrom 13 Years to 17 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT03260205
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
ADHDOtherFrom 4 Years to 5 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT02604407
This study exists to compare options and see whether the medication SHP465 offers something meaningfully different. Researchers are trying to understand how people respond to the medication SHP465 in practice and what may need to be adjusted.
ADHDOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
WithdrawnNCT01274221
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
ADHDOtherFrom 13 Years to 17 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
TerminatedNCT03325894
This study exists to understand how the medication SHP465 holds up over time after the earliest research stage. Researchers are trying to understand whether the medication SHP465 can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 4 Years to 12 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT02466425
This study exists to compare options and see whether the medication SHP465 offers something meaningfully different. Researchers are trying to understand how people respond to the medication SHP465 in practice and what may need to be adjusted.
ADHDOtherFrom 6 Years to 17 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT03325881
This study exists to understand whether this type of care is both safe enough and useful enough to take further. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 6 Years to 12 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT00557960
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
ADHDOtherFrom 19 Years to 25 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT02578030
This study exists to explore whether this type of care could improve care and understanding. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.
ADHDOtherFrom 6 Years to 17 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT01727414
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 7 Years to 11 Years
- Countries
- United States
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Condition
- ADHD
CompletedNCT01681082
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 18 Years to 23 Years
- Countries
- United States
- Sponsor
- University of Wisconsin, Madison
- Condition
- ADHD
CompletedNCT02803229
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
- Condition
- ADHD
CompletedNCT04138498
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
ADHDOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Cingulate Therapeutics
- Condition
- ADHD
CompletedNCT04817059
This study exists to understand whether a digital app or remote support tool is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
ADHDOtherFrom 5 Years to 10 Years
- Countries
- United States
- Sponsor
- University of Texas at Austin
- Condition
- ADHD
CompletedNCT02428088
This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.
ADHDOtherFrom 6 Years to 12 Years
- Countries
- United States
- Sponsor
- Sumitomo Pharma America, Inc.
- Condition
- ADHD
CompletedNCT02466386
This study exists to understand how the medication SPD489 holds up over time after the earliest research stage. Researchers are trying to understand whether the medication SPD489 can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 4 Years to 5 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT01364662
This study exists to see whether the medication SPN-810 can play a useful role in care. Researchers are trying to understand whether the medication SPN-810 can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 6 Years to 12 Years
- Countries
- United States
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Condition
- ADHD
CompletedNCT02694939
This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 11 Years to 17 Years
- Countries
- United States
- Sponsor
- Florida International University
- Condition
- ADHD
CompletedNCT03042338
This study exists to see whether this type of care is workable and worth testing more broadly. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 8 Years to 13 Years
- Countries
- United States
- Sponsor
- Florida State University
- Condition
- ADHD
CompletedNCT04473755
This study exists to see whether the medication Functional can make care clearer and more responsive. Researchers are trying to understand whether the medication Functional can improve sleep, daily rhythms, and longer-term stability.
ADHDOtherFrom 16 Years to 30 Years
- Countries
- United States
- Sponsor
- Florida International University
- Condition
- ADHD
CompletedNCT01924143
This study exists to explore whether the medication TD-9855 could improve care and understanding. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.
ADHDOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- Theravance Biopharma
- Condition
- ADHD
CompletedNCT02874690
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 8 Years to 21 Years
- Countries
- United States
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Condition
- ADHD